Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48
Why have early AI drug-discovery companies often overpromised but underdelivered? Biology is still complex and...
Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47
Valneva now has three commercialized vaccines and a Lyme disease candidate in Phase 3. Philip...
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46
When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge...
Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45
As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into...
![Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]](https://flot.bio/wp-content/uploads/2025/10/Website-Thumbnail-Gerrit-Sitters-1080x648.avif)
Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]
As Philip tours Amsterdam, he visits the biotech tools startup LUMICKS. Founded in 2014, the...
Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43
We travel to the offices of Pharming Group in Leiden, the Netherlands, to chat with...
![Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored]](https://flot.bio/wp-content/uploads/2025/10/Website-Thumbnail-Daniela-Marino-1080x648.avif)
Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored]
Hot on the heels of CUTISS’ $60M Series C round, we catch up once more...
Dragan Grabulovski, Araris 🇨🇭 | ADC Linkers, Replacing Chemotherapy | E41
Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to...
Stefano Portolano, Azafaros 🇳🇱 🇨🇭 | Rare Diseases, Small Molecules | E40
On a trip to Basel, Switzerland, Philip catches up with Stefano Portolano, CEO of the...
Alex Zhavoronkov, Insilico Medicine | AI Drug Development, Longevity | E39
We chat about longevity with Alex Zhavoronkov, CEO and founder of the artificial intelligence (AI)...
Never Miss a New Episode 💌
Trusted by 2500+ biopharma professionals from top companies like argenx, Roche, and Forbion. No spam, no noise.
Watch & Subscribe
